Real-world monitoring of direct oral anticoagulants in clinic and hospitalization settings

SAGE Open Medicine
Seiji TakatsukiKeiichi Fukuda

Abstract

The monitoring of the effects of direct oral anticoagulants may be beneficial during emergencies and adverse events. We aimed to explore direct oral anticoagulant monitoring in "real-world" settings, in which monitoring methods are limited and loading time can be estimated based on only patient reports. In 164 patients, plasma anti-Xa activity was assessed using a STA(®)-Liquid Anti-Xa reagent (Diagnostica Stago, Asnieres, France), and prothrombin time was measured using HemosIL(®) RecombiPlasTin 2G (Instrumentation Laboratory, Bedford, MA, USA). The loading time was calculated according to the previous dosing time reported by the patient. In the clinic setting, rivaroxaban and apixaban were administered to 103 patients with atrial fibrillation and a blood sample was tested once during a clinic visit. In the hospitalization setting, edoxaban was administered to 61 patients undergoing arthroplasty for prophylaxis of a venous thrombosis and blood samples were tested 3 and 18 h after the last intake. Plasma Xa activity in the clinical setting ranged widely (rivaroxaban: 1.1-424.4 ng/mL, apixaban: 15.4-469.2 ng/mL) during the 11.7 ± 7.0 h following the previous dose. The values varied over a wide range (up to a factor of 2) at the ...Continue Reading

References

Dec 22, 2011·Thrombosis and Haemostasis·Meyer Michel SamamaUNKNOWN Rivaroxaban Anti-Factor Xa Chromogenic Assay Field Trial Laboratories
Jun 15, 2013·Thrombosis and Haemostasis·Jonathan DouxfilsFrançois Mullier
Apr 4, 2014·Emergency Medicine International·Jürgen Koscielny, Edita Rutkauskaite
Jun 27, 2014·Journal of Thrombosis and Haemostasis : JTH·A HillarpT L Lindahl
Jul 22, 2014·Journal of Thrombosis and Haemostasis : JTH·L-A Linkins, K Moffat
Nov 6, 2014·The New England Journal of Medicine·Jack E AnsellJames C Costin
Dec 6, 2014·Thrombosis Research·Suman RathbunRichard A Marlar
Aug 19, 2015·Clinical Medicine Insights. Case Reports·Dimitar Sajkov, Alexander Gallus
Apr 12, 2016·Journal of Thrombosis and Haemostasis : JTH·L A LinkinsM A Crowther
Nov 5, 2016·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Sarah LessireFrançois Mullier

❮ Previous
Next ❯

Citations

Oct 29, 2020·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Aldo SalviGiancarlo Agnelli
May 1, 2021·Biomedicines·Claire Dunois

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Jacob BeyerTyree H Kiser
European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
Thomas EllerIngvild Birschmann
© 2022 Meta ULC. All rights reserved